Clinical Trials Analysis and Real-world Evidence – Where is the Frontier?
On Tuesday September 12th in Chilly-Mazarin was attended by an audience of 90 people from 31 companies. For the first time, it took place in Sanofi Chilly-Mazarin. The theme of the day was “Clinical Trials Analysis and Real-world Evidence – Where is the frontier?” and was the opportunity to share experiences on the new concepts, trends and solutions related to interoperability and technology used to support both Randomized Clinical Trials (RCT) and Real-world Data (RWD).
Overall, the attendees feedback mentioned the good quality of presentations from high professionals, the enjoyable spirit and the good networking opportunities. Attendees got inspired by the wide range of interesting and excellent talks which complemented each other very well. Thank you to our valued attendees, presenters and sponsors for their participation. Looking forward to seeing you at a next PHUSE Chilly-Mazarin SDE!
RWE in Pharma: Does the Emperor have Clothes? – Florent Richy, Business & Decision Life Sciences
A Flexible Approach to Multi-Source Data Imputation – How it Works and Expected Results – James Hunter, OCS Life Sciences
Why an "RWE Integrated Platform" is a Key Enabler to Realize our Ambition – Rémi Chossinand, Sanofi
Machine Learning and IOT for Medical Prevention. A View From the Tranches – Pierre Gutierrez, Dataiku
Providing the Real World Value of New Medicines – Mark Lambrecht, SAS
RWE Applications: Using Healthcare Data to Understand Population Treatment Effects of Pharmaceutical Therapies – Taylor Pressler, d-Wise
Aim for the Stars – The Use of Metadata to Manage your Clincial Data – Niels Booth, S-cubed
PHUSE Updates – Katja Glass, Bayer
Download the event brochure here.